Cellular cardiomyoplasty using skeletal myoblasts may be beneficial for infarct repair. One drawback to skeletal muscle cells is their lack of gap junction expression after differentiation, thus preventing electrical coupling to host cardiomyocytes. We sought to overexpress the gap junction protein connexin43 (Cx43) in differentiated skeletal myotubes, using retroviral, adenoviral, and plasmid-mediated gene transfer. All strategies resulted in overexpression of Cx43 in cultured myotubes, but expression of Cx43 from constitutive viral promoters caused significant death upon differentiation. Dye transfer studies showed that surviving myotubes contained functional gap junctions, however. Retrovirally transfected myoblasts did not express Cx43 after grafting into the heart, possibly due to promoter silencing. Adenovirally transfected myoblasts expressed abundant Cx43 after forming myotubes in cardiac grafts, but grafts showed signs of injury at 1 week and had died by 2 weeks. Interestingly, transfection of already differentiated myotubes with adenoviral Cx43 was nontoxic, implying a window of vulnerability during differentiation. To test this hypothesis, Cx43 was expressed from the muscle creatine kinase (MCK) promoter, which is active only after myocyte differentiation. The MCK promoter resulted in high levels of Cx43 expression in differentiated myotubes but did not cause cell death during differentiation. MCK-Cx43-transfected myoblasts formed viable cardiac grafts and, in some cases, Cx43-expressing myotubes were in close apposition to host cardiomyocytes, possibly allowing electrical coupling. Thus, high levels of Cx43 during skeletal muscle differentiation cause cell death. When, however, expression of Cx43 is delayed until after differentiation, using the MCK promoter, myotubes are viable and express gap junction proteins after grafting in the heart. This strategy may permit electrical coupling of skeletal and cardiac muscle for cardiac repair.
INTRODUCTION M
. Cellular cardiomyoplasty represents a potentially promising strategy to replace the noncontractile fibrous scar tissue with new contractile muscle. Skeletal myoblasts are being explored as a cell source for cardiomyoplasty for several reasons: (1) availability from any given patient, thus providing an autologous, nonimmunogenic source of cells, (2) potent proliferative capacity, (3) resistance to ischemia, and (4) contractility. A major theoretical caveat concerning the use of skeletal muscle cells for cardiac repair is their lack of gap junctions that mediate electrical coupling. In contrast, electrical coupling between heart muscle cells is dependent on connexin43 (Cx43)-rich gap junctions (Beyer et al., 1987) . Interestingly, skeletal muscle cells express Cx43 as replicating myoblasts but downregulate its expression progressively upon fusion, myotube formation, and further differentiation (Schmalbruch, 1982; Balogh et al., 1993) . As a result, mature skeletal myofibers become electrically insulated, permitting fine motor control to be achieved by innervation with motoneurons.
A previous study from our laboratory has shown that primary skeletal myotubes can couple to cardiomyocytes via electromechanical junctions in vitro, thus inducing synchronous, calcium-dependent contractions in the skeletal muscle cells. This indicated that low-level Cx43 expression was sufficient to achieve electrical coupling in vitro. Electromechanical coupling was not detectable in skeletal muscle grafts in the heart, however, because the skeletal muscle cells did not express the critical junctional molecules in vivo . These experiments led us to hypothesize that forced expression of Cx43 in differentiated skeletal myocytes would allow electrical coupling of these cells to the host cardiomyocytes after cardiac grafting.
MATERIALS AND METHODS

Strategies to overexpress Cx43 in differentiated skeletal myocytes
Our initial goal was to generate a myoblast clone with stable expression of the transgene Cx43 after differentiation. Therefore, we chose the mouse myoblast line MM14 (kindly provided by S. Hauschka, University of Washington, Seattle, WA). The MM14 myoblast line shows growth characteristics similar to those of primary myoblasts but is dependent on basic fibroblast growth factor (bFGF) for continuous proliferation (Linkhart et al., 1981) . MM14 myoblasts were used for transduction with a Cx43-retrovirus. To more closely mimic a clinical situation, we also wished to test overexpression of Cx43 in primary myoblasts. To achieve high-efficiency infection of primary myoblasts we generated a Cx43-adenovirus and used Fischer neonatal rat primary myoblasts as target cells. The mouse myoblast line C2C12 (American Type Culture Collection [ATCC], Manassas, VA) was used for plasmid transfections. The culture conditions for the three cell types were as described previously in detail . The rat Cx43 cDNA was kindly provided by E.C. Beyer (University of Chicago, Chicago, IL).
Animal procedures
The study protocol was approved by the Institutional Animal Care and Use Committee of the University of Washington and was conducted in accordance with federal guidelines. Normal hearts of adult male nude mice were injected with a standard dose of 1 ϫ 10 6 myoblasts suspended in 7 l of medium without serum and antibiotics as previously described in detail (Reinecke and Murry, 2003) . Mice were killed 7, 10, or 14 days after grafting and their hearts were fixed in methyl Carnoy's solution and routinely processed for histology as described previously (Murry et al., 1996b; . Subcutaneous grafting (referred to as "skin grafts") was used as a relatively simple test model to evaluate transgene expression in vivo. Typically, 5 ϫ 10 6 myoblasts were suspended in 50 l of serum and antibiotic-free medium and injected subcutaneously (4-6 grafts on the back of the mouse). The skin grafts were recovered 1-2 weeks after transplantation and routinely processed for histology (paraffin-embedded or cryosections).
Antibodies and immunocytochemistry
Immunostaining of deparaffinized sections was performed by routine staining techniques as previously described (Murry et al., 1996b; Reinecke et al., 1999 Reinecke et al., , 2002 . A monoclonal connexin43 antibody (Chemicon International, Temecula, CA) was used for single immunostaining (diluted 1:200) and Western blotting (diluted 1:1000). In double-staining reactions sections were first incubated with the MY32 antibody (Havenith et al., 1990 ) (alkaline phosphatase-conjugated anti-fast skeletal myosin heavy chain, diluted 1:400; Sigma, St. Louis, MO) and then with a polyclonal connexin43 antibody (diluted 1:5000; Chemicon International). Vector red (Vector Laboratories, Burlingame, CA) was used as the first chromogen and diaminobenzidine (DAB; Sigma) was used as the second chromogen.
Cx43 retrovirus production and transduction
Production of the retrovirus encoding rat Cx43 closely followed a protocol developed by Miller and colleagues (1993) . Briefly, rat Cx43 cDNA was digested with EcoRI and ligated into the EcoRI site of the LXSN retroviral backbone (LTR driving expression of the transgene, X ϭ transgene, SV40 promoter driving the resistance gene, Neomycin phosphotransferase; generously provided by A.D. Miller, Fred Hutchinson Cancer Research Center, Seattle, WA) . The resulting LCx43SN plasmid was used for transient transfection of ecotropic PE501 packaging cells. A 24-hr supernatant from these cells was used to infect amphotropic PA317 packaging cells. After 14 days of culture in selection medium containing G418 (Geneticin, 1.6 mg/ml; Invitrogen, Carlsbad, CA), 12 neomycin-resistant clones were selected for further analysis. Integration of the retroviral construct into genomic DNA was tested by polymerase chain reaction (PCR). For mass production of the Cx43-retrovirus a positive cell clone was expanded, and the supernatant was collected and used to transduce the mouse myoblast line MM14. For the transduction of MM14 myoblasts the retrovirus-containing supernatant was mixed with basic fibroblast growth factor (bFGF)-containing growth medium (1:1) and MM14 cultures were incubated for 24 hr with the retrovirus. Regular growth medium was then added back. Two days after transduction, selection for neomycin resistance was started by adding G418 (1.6 mg/ml) to the growth medium. Stably transduced MM14 clones were picked after 14 days, using cloning rings. The clones were expanded and analyzed for expression of the Cx43 transgene after differentiation by Western blot anal-ysis and immunostaining. As a control, an empty LXSN retrovirus without transgene was generated and used to derive an "empty" transduced MM14 clone.
Cx43 adenovirus production and infection
An adenovirus encoding rat Cx43 driven by the cytomegalovirus (CMV) promoter was generated by using the AdEasy system originally described by He and colleagues (1998) 
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Analysis of gap junction function by microinjection. Myotubes transduced with the empty retrovirus or Cx43-retrovirus were injected with rhodamine dextran (gap junction-impermeable dye) and Lucifer yellow (gap junction-permeable dye) 6 days after induction of differentiation. Dye transfer of Lucifer yellow was absent between myotubes transduced with the empty retrovirus (C-F). In contrast, Cx43-transduced myotubes readily permitted Lucifer yellow dye transfer to adjacent myotubes, suggesting functional gap junctions (G-J). (K and L) Cardiac grafting of MM14 myoblasts transduced with the Cx43-retrovirus into normal nude mouse hearts. On day 10 after grafting, hematoxylin and eosin (H&E) staining revealed the presence of multinucleated skeletal myotubes (K, arrows). Immunostaining for Cx43 on consecutive sections, however, failed to detect expression of the transgene in the graft. In contrast, Cx43-positive gap junctions were readily detected in the intercalated disks of host myocardium (L, arrowhead). Original magnification: ϫ400.
gestion with PmeI and subsequently cotransformed, using electroporation-competent Escherichia coli BJ5183 cells with the adenoviral backbone plasmid pAdEasy-1. Recombinants were selected for kanamycin resistance, and recombination was confirmed by restriction endonuclease analyses. Finally, the PacI-linearized recombinant plasmid was transfected into adenovirus packaging cell line 293. Mass production of adenoviruses was performed as described previously (Murry et al., 1996a) . The concentration of the adenovirus preparations was measured by spectrophotometry. An optical density (OD) at 260 nm of 1 equals approximately 10 12 viral particles/ml. Primary neonatal Fischer rat myoblasts were grown in gelatin-coated 100-mm plates in F10C supplemented with 15% horse serum, bFGF (6 ng/ml), and antibiotics (Murry et al., 1996b; . The day before grafting, the myoblast cultures were infected with 500 viral particles/cell in 5 ml of medium for 2.5 hr with agitation in a humidified incubator (37°C, 5% CO 2 ). Cell viability was confirmed the next day by trypan blue staining, and myoblasts were prepared for cardiac injection as described (Murry et al., 1996b; .
Muscle creatine kinase promoter-Cx43 plasmid vector
The backbone of this construct was kindly provided by S. Hauschka (University of Washington, Seattle, WA) and consisted of a full-length muscle creatine kinase (MCK) promoter (Jaynes et al., 1986 (Jaynes et al., , 1988 , a multicloning site, and kanamycin and neomycin resistance genes for selection in prokaryotes and eukaryotes, respectively. The MCK gene is inactive in myoblasts but is transcriptionally activated during striated muscle differentiation and is expressed at high levels in adult heart and skeletal muscles (Chamberlain et al., 1985; Lyons et al., 1991) . Thus, on differentiation the Cx43 transgene becomes activated whereas the endogenous Cx43 gene expression is muted. This vector was digested, utilizing the NotI and AgeI sites. Compatible NotI and AgeI sites for Cx43 were generated by PCR. The PCR product was agarose gel purified, and a mutation-free clone was obtained after sequencing, termed pMCK-Cx43. C2C12 myoblasts were transfected with pMCK-Cx43, using SuperFect transfection reagent (Qiagen, Valencia, CA). Stable lines were selected on the basis of neomycin resistance (G418, 1.6 mg/ml).
Cx43 expression screening
To screen for the expression and function of the Cx43 transgene in vitro we employed Western blot analysis, immunostaining, and microinjection (dye transfer) as described . For Western blot analysis typically 80-100 g of protein from a total cell lysate was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted, and the membrane was probed with a monoclonal anti-Cx43 antibody. For immunocytochemistry cultures were routinely fixed with icecold 100% methanol. If detection of both GFP and connexin43 immunostaining was required, cultures were fixed for 2 min in 3% paraformaldehyde, 0.2% Triton X-100, and 5 mM EGTA in phosphate-buffered saline (PBS) (pH 7.2), rinsed with PBS, and then fixed for 20 min in 3% paraformaldehyde. Connexin43 was detected with a mouse monoclonal antibody (diluted 1:200; Chemicon International). Microinjection studies were performed to evaluate functional gap junctions between differentiated myotubes as described previously . The injected dye solution was composed of 10% Lucifer yellow (gap junction permeable) and 10% tetramethylrhodamine-dextran (gap junction impermeable) (Molecular Probes, Eugene, OR). The injected cultures were fixed with 4% paraformaldehyde and cell nuclei were counterstained with Hoechst 33342 (Molecular Probes).
RESULTS
Retrovirus-mediated Cx43 expression in MM14 myoblasts
We established several lines of MM14 mouse myoblasts transduced with the Cx43 retrovirus. Expression of the transgene was driven by the viral long terminal repeat (LTR) promoter. It is known that primary myoblasts as well as immor-
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In vitro characterization of primary Fischer rat myoblasts infected with GFP-adenovirus (control) or Cx43-GFP-adenovirus and then differentiated for 5 days. Ad-GFP-infected myotubes did not express Cx43 (A-D). In contrast, Cx43 expression was readily detected in differentiated myotubes infected with the Cx43-adenovirus (E-H). Both control (I-L) and Cx43-adenovirus (M-P)-infected myotubes expressed fast skeletal muscle-specific myosin heavy chain (MHC fast; detected with the MY32 antibody; Sigma) (Havenith et al., 1990) . Green, GFP fluorescence; blue, Hoechst 33342 used as a nuclear counterstain. Original magnification: ϫ400.
FIG. 3.
Primary Fischer rat myoblasts were infected with GFP-adenovirus (control) or Cx43-GFP adenovirus and grafted subcutaneously into nude mice (skin graft model). Myoblasts infected with control GFP-adenovirus gave rise to differentiated skeletal muscle grafts (A), whereas myoblasts infected with the Cx43-adenovirus (also encoding GFP) did not yield viable grafts (B). Green, GFP fluorescence; blue, Hoechst 33342 used as a nuclear counterstain. (C-F) Interestingly, if already differentiated myotubes were infected in vitro, both GFP-adenovirus-infected myotubes (C and D) and Cx43-adenovirus-infected myotubes (E and F) appeared viable. Top: Phase-contrast. Bottom: GFP fluorescence (green). Primary Fischer rat myoblasts infected with lowdose Cx43-adenovirus were grafted into normal nude mouse hearts. (G) At 1 week after grafting hematoxylin and eosin staining revealed the presence of multinucleated skeletal myotubes (G, inset) . Immunostaining for Cx43 on consecutive sections detected abundant expression of the transgene in the graft (brown) (H). Possible sites of gap junctional communication between graft myotubes and host cardiomyocytes were rarely observed (I and J, arrowheads). Many Cx43-expressing myotubes, however, showed signs of cell injury, including swelling of subcellular compartments (K and L). Original magnification: (A and B) ϫ400; (C-F) ϫ200; (G and H) ϫ40; (G, inset, and I-L) ϫ1000.
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talized myoblast lines express endogenous Cx43, which appears to be required for normal fusion (Mege et al., 1994) . Therefore, we analyzed the expression levels of transgenic Cx43 in differentiated myotubes by Western blot analysis (Fig. 1A) . Nontransfected (wild-type) myoblasts expressed abundant levels of Cx43, and this was significantly downregulated upon differentiation into myotubes. Myotubes that had been previously transduced with a control (empty) retrovirus showed similarly low levels of Cx43 protein. In contrast, myoblasts transduced with the Cx43-encoding retrovirus showed high levels of Cx43 expression after differentiating into myotubes.
In myoblasts transduced with the Cx43-retrovirus we noticed increased cell death upon differentiation (Fig. 1B) . In contrast, a myoblast clone transduced with the control (empty) retrovirus showed normal fusion and differentiation, thus excluding retroviral transduction itself as the cause of increased cell death. Microinjection studies performed on surviving myotubes showed that Cx43-transduced myotubes permitted Lucifer yellow dye transfer (Fig. 1G-J) . In contrast, dye transfer was not observed in myotubes transduced with an empty retrovirus ( Fig. 1C-F) . In both cases, however, microinjection of MM14 myotubes frequently resulted in hypercontraction and subsequent detachment from the surface. A clone showing robust Cx43 expression levels in differentiated myotubes was chosen for grafting studies. Both MM14 myoblasts transduced with empty retrovirus (control) and MM14 myoblasts transduced with Cx43 retrovirus gave rise to viable grafts in nude mouse hearts. We were not able, however, to detect Cx43 expression in the MM14-Cx43 grafts 10 days (n ϭ 7) (Fig. 1K and L) and 4 weeks (n ϭ 4) after grafting. The absence of Cx43 expression suggests possible silencing of the retroviral LTR promoter in vivo. Extinction of retroviral vector expression has been previously observed after implantation of transduced embryonic and hematopoietic stem cells as well as fibroblasts, myoblasts, and hepatocytes (Lund et al., 1996; Cherry et al., 2000) .
Adenovirus-mediated Cx43 expression in primary Fischer rat myoblasts
The rationale behind using primary myoblasts as target cell for connexin43 gene transfer is given by the clinical situation. Here, one would need to isolate satellite cells from a given patient and genetically modify these cells efficiently. To mimic this situation, we generated an adenovirus encoding Cx43 (and also GFP, each driven by separate CMV promoters) and infected cultures of undifferentiated primary Fischer rat myoblasts. Immunostaining demonstrated the expression of connexin43 in differentiated myotubes infected with the Cx43-adenovirus (Fig.  2E-H) but not in myotubes infected with the control GFP-adenovirus ( Fig. 2A-D) . Both the GFP-and Cx43-GFP-infected myotubes expressed typical muscle markers such as desmin (data not shown) and fast skeletal myosin heavy chain ( Fig. 2I-P) .
Similar to our observations with the Cx43-retrovirus, we noticed increased cell death on differentiation in cultures infected with Cx43-adenovirus but not in cultures infected with a GFPadenovirus (data not shown). To test whether Cx43-expressing myoblasts showed similar susceptibility to death in vivo, primary myoblast cultures were infected with the control GFP-adenovirus or the Cx43-adenovirus and then grafted subcutaneously into nude mice. Figure 3A shows that myoblasts infected with the control GFP-adenovirus gave rise to green fluorescent differentiated myofibers. In contrast, myoblasts infected with the Cx43-adenovirus did not yield viable grafts (Fig.  3B) . Interestingly, if already differentiated cultures were infected with the Cx43 adenovirus, no increase in cell death was observed in vitro, and infected myotubes appeared healthy (Fig.  3C-F) .
Reduction in cell death by transfection after differentiation suggests that Cx43 levels need to be tightly regulated during critical steps in the differentiation process or otherwise may have adverse effects on cell survival. Unfortunately, trypsinizing differentiated primary myotubes (as necessary for grafting experiments) causes massive cell death. Therefore, we infected undifferentiated myoblasts with the Cx43-adenovirus at ϳ30% efficiency, reasoning that this relatively low infection rate would yield lower, nontoxic Cx43 levels, yet result in a high percentage of Cx43-positive myotubes due to fusion of infected with noninfected myoblasts. One week after grafting into normal nude mouse hearts the Cx43-infected myoblasts had differentiated to form myotubes ( Fig. 3G and inset) . Despite the relatively low infection rate, staining for Cx43 revealed abundant expression of the transgene (Fig. 3H) . Although Cx43 is typically localized to the cell membrane, the transfected myotubes demonstrated diffuse cytoplasmic staining. In rare cases, we observed possible sites of gap junctional communication between host and graft ( Fig. 3I and J) . Many of the Cx43-expressing graft myotubes appeared atrophic and had perinuclear vacuoles ( Fig. 3K and L ), suggesting problems with intracellular volume regulation.
Expression of muscle creatine kinase promoter-Cx43 in C2C12 myoblasts
Previous studies indicated that overexpressing Cx43 during muscle differentiation caused cell death, but that AdCx43 infection of already differentiated myotubes was well tolerated. We therefore hypothesized that a promoter active only in differentiated skeletal muscle would result in myotubes that expressed Cx43 in a nontoxic fashion. We therefore selected the muscle creatine kinase (MCK) promoter, which is transcriptionally activated during striated muscle differentiation and is expressed at high levels in adult heart and skeletal muscles (Chamberlain et al., 1985; Lyons et al., 1991) . Thus, the Cx43 transgene should be active only in differentiated myocytes (while the endogenous Cx43 gene expression is muted), but not in undifferentiated myoblasts. It is also known that the fulllength 3.3-kb MCK promoter, as used in our construct, is approximately 8% as active as the CMV promoter in myocytes (Hauser et al., 2000) .
C2C12 myoblasts stably transfected with the MCK-Cx43 plasmid showed normal growth, and no increase in cell death was observed on differentiation ( Fig. 4A-C) . Western blot analysis of cell lysates prepared from day 7 differentiated wild-type and Cx43-transfected myotubes revealed persistent overexpression of the transgene (Fig. 4D) . Several MCK-Cx43-expressing C2C12 clones were then tested in the subcutaneous graft model and grafts were analyzed at 1 week. In most clones expression of the Cx43 transgene was readily detectable, indicating that this mammalian promoter was not silenced in vivo (data not shown). The clone with the most abundant expression was then grafted into normal nude mouse hearts. In contrast to myoblasts infected with the Cx43 adenovirus, the MCK-Cx43-transfected myoblasts formed viable, differentiated grafts even 2 weeks after grafting. The grafts robustly expressed Cx43, and in some cases there was evidence of Cx43-positive junction formation between graft myotubes and host cardiomyocytes ( Fig.   4E and F) . These experiments suggest that expression of Cx43 in differentiated myotubes may be consistent with survival and functional integrity of skeletal myocytes.
Finally, we tested whether differences in the susceptibility to death could be attributed to different promoters (LTR, CMV versus MCK) and timing of Cx43 transgene expression or sim-
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FIG. 4.
Characterization of an MCK-Cx43-overexpressing C2C12 clone. Phase-contrast photomicrographs of stably transfected undifferentiated myoblasts (A) and subsequently differentiated, day 7 myotubes (B). Immunostaining for Cx43 showed abundant expression of the transgene in the differentiated C2C12 myotubes (C) (mouse monoclonal Cx43 antibody [Chemicon International]; rabbit anti-mouse FITC-conjugated secondary antibody). Western blot analysis (D) of wild-type C2C12 myotubes and C2C12 cells transfected with MCK-Cx43 plasmid. Wild-type C2C12 myotubes expressed low but detectable levels of Cx43. In contrast, transfected cells expressed elevated levels of the Cx43 transgene. Cell lysates of myotubes were prepared on day 7 after induction of differentiation. Cardiac grafting of C2C12 myoblasts transfected with the MCK-Cx43 plasmid into normal nude mouse hearts (E and F). Heart sections were immunostained for fast skeletal myosin heavy chain (red) and Cx43 (brown) 1 week after grafting. In some cases Cx43 was localized at the interface between graft myotubes (graft) and host cardiomyocytes (host), suggesting gap junctional coupling (E and F, arrows). The arrowhead in (F) indicates the connexin43-positive intercalated disk between two coupled host cardiomyocytes. Original magnification: (A-C) ϫ200; (E and F) ϫ1000.
ply the different cell types used. We therefore infected wildtype C2C12 myoblasts with AdGFP or AdCx43-GFP and switched the cultures to differentiation 24 hr after infection. Similar to our previous results with primary myoblasts, AdCx43-infected C2C12 cells showed increased cell death compared with AdGFP-infected cultures (data not shown). In contrast, if differentiated C2C12 myotubes were infected with the Cx43 adenovirus no increase in cell death was observed, again suggesting that the right timing of Cx43 overexpression is critical in skeletal muscle cells.
DISCUSSION
In the present study we investigated overexpression of the gap junction molecule connexin43 in skeletal muscle cells, the rationale being the use of these cells for cardiac repair (cellular cardiomyoplasty). In contrast to skeletal muscle, the proper function of cardiac muscle heavily relies on the presence of gap junctions. Before fusion, myoblasts predominantly express the endogenous Cx43 gap junction protein, but this expression is downregulated once fusion is initiated (Balogh et al., 1993) . Therefore, our goal was to achieve overexpression of connexin43 in differentiated skeletal myotubes. The major findings are as follows: (1) constitutive expression of Cx43 in myoblasts appears to interfere with cell fusion and survival; and (2) overexpression of connexin43 in differentiated myotubes may be achieved by using promoters active only in differentiated skeletal myocytes (such as the muscle creatine kinase promoter) or transfection of already differentiated myotubes.
Using three different strategies, that is, retrovirus-, adenovirus-, and plasmid-based vectors encoding rat connexin43 (Beyer et al., 1987) , we achieved overexpression in undifferentiated myoblasts (mouse C2C12 and MM14 cells, and neonatal rat primary myoblasts) without apparent negative effects on the transfected cells under growth conditions. Expression of the Cx43 transgene was also tolerated when already differentiated myotubes were transfected or when connexin43 expression was driven by the muscle creatine kinase promoter. It is important to note that the MCK promoter is inactive in myoblasts but is transcriptionally activated during striated muscle differentiation (Chamberlain et al., 1985; Lyons et al., 1991) . Thus, both conditions yielded expression of the Cx43 transgene in differentiated myotubes.
In contrast, massive cell death during differentiation was observed when undifferentiated myoblasts were transfected with constitutively active connexin43 vectors and then subjected to differentiation. Surviving myotubes, however, permitted dye transfer of Lucifer yellow (Fig. 1) , indicating functional integrity of the rat Cx43 transgene in mouse cells. In vivo after cardiac grafting, we failed to detect any connexin43 expression in MM14-derived grafts, possibly due to silencing of the retroviral LTR promoter in vivo as reported in other systems (Lund et al., 1996; Cherry et al., 2000) or selective survival of myotubes with low expression levels, thus eluding immunodetection. The latter appears less likely, however, given the robust Cx43 protein levels (by Western blot) detected in surviving Cx43-transduced myotubes. Similarly, primary myoblasts and C2C12 myoblasts infected with the CMV-Cx43 adenovirus showed increased cell death upon differentiation in vitro and in vivo after subcutaneous or cardiac grafting. Taken together, these results suggest that constitutively high levels of Cx43 may interfere with critical steps during myoblast fusion.
Gap junctions are found in nearly all mammalian tissues, with adult skeletal muscle being one notable exception, although they are present in early developing myoblasts (Schmalbruch, 1982; Balogh et al., 1993) . The differentiation of cultured skeletal myoblasts is commonly activated by growth factor withdrawal and accompanied by transcriptional activation of muscle-specific genes, growth arrest, and fusion to form multinucleated myotubes (Olson, 1992 (Olson, , 1993 . The muscle-specific basic helix-loop-helix transcription factors, including MyoD, Myf5, myogenin, and MRF4, orchestrate the entire expression program of the various muscle-specific genes, fast skeletal myosin heavy chain and muscle creatine kinase. In our study we successfully used the muscle creatine kinase promoter to drive expression of Cx43. The MCK-Cx43-transfected cells proliferated and differentiated normally and the Cx43 transgene was expressed in myotubes in vitro and in vivo after subcutaneous or cardiac grafting. Because the MCK promoter is only approximately 8% as active as the CMV promoter in myocytes (Hauser et al., 2000) , one might speculate that differences in the transcriptional activity of the MCK versus viral promoters (LTR, CMV) may have caused the different outcomes. At least for CMV-driven Cx43 this appears unlikely, because differentiated myotubes transfected with CMV-Cx43 adenovirus appeared viable. It then becomes likely that the timing of Cx43 transgene expression plays the more important role. Our results suggest that improper levels of Cx43 at the time of transition from proliferation to differentiation triggered cell death. This could explain the successful expression of the Cx43 transgene in undifferentiated myoblasts maintained under conditions promoting proliferation and in differentiated myotubes (by transfection of already differentiated myotubes or by using the MCK promoter).
Our data contrast somewhat with a previous study by Suzuki and colleagues, who also sought to enhance intercellular communication of skeletal with cardiac myocytes (Suzuki et al., 2001) . These authors overexpressed Cx43 in L6 rat skeletal myoblasts, using the human CMV promoter, the same promoter used in our adenovirus approach. They reported that Cx43-transfected myoblasts more rapidly fused and differentiated into multinucleated myotubes. It is possible that the L6 cell line used in the Suzuki et al. study may be less susceptible to the detrimental effects of Cx43 overexpression that we observed. On the other hand, most of their presented data documented successful overexpression of the transgene in undifferentiated myoblasts. In agreement with the current work, overexpression of Cx43 by myoblasts was well tolerated.
Proper function of cardiac muscle relies on the presence of gap junctions located in the intercalated disks of neighboring cardiomyocytes. Despite the fact that mature skeletal myocytes do not express gap junction molecules, they have become a major focus of cellular cardiomyoplasty (Leobon et al., 2003) . Currently, autologous skeletal myoblast transplantation for cardiac infarct repair is undergoing clinical trials (Menasche et al., 2001 Pagani et al., 2003) . We hypothesized that expression of gap junctions would enable skeletal muscle cells to electrically couple to host cardiomyocytes, thus providing a physiologically more potent graft cell for the heart. Although retrovirally transduced skeletal muscle cells did not express Cx43 after cardiac grafting (Fig. 1) , primary myoblasts infected with the Cx43-adenovirus gave rise to intensely Cx43-positive cardiac grafts (Fig. 3) . Furthermore, we observed Cx43-positive myotubes in close apposition to host cardiomyocytes, perhaps allowing for coupling. Many graft cells expressing Ad-CMV-Cx43, however, showed signs of cell injury, including swelling of subcellular compartments (Fig. 3) . The most promising results were obtained with the muscle creatine kinase promoter driving expression of Cx43 in differentiated skeletal muscle cells. When these cells were grafted we observed myotubes in close apposition with host cardiomyocytes, and in some cases Cx43 immunostaining was suggestive of coupling between host and graft via Cx43-positive junctions (Fig.  4) . Physiological studies will be required to test definitively whether such coupling has occurred (Rubart et al., 2003) .
In summary, we have shown that overexpression of the major gap junction protein of the heart, Cx43, is feasible in skeletal muscle cells. Our experiments suggest that Cx43 transgene expression is consistent with cell survival in differentiated cells. In contrast, high levels of transgenic Cx43 in myoblasts undergoing differentiation appeared to be toxic, leading to cell death. We believe that myoblasts expressing Cx43 under the control of the MCK promoter will allow us to investigate whether gap junction formation between cardiac and skeletal muscle can indeed take place, and if so, whether such coupling will promote contractile function or exert arrhythmic potential.
